tiprankstipranks
Trending News
More News >
Dr. Martens Plc (GB:DOCS)
LSE:DOCS
UK Market
Advertisement

Dr. Martens Plc (DOCS) Share Forecast & Price Target

Compare
143 Followers
See the Price Targets and Ratings of:

DOCS Analyst Ratings

Hold
6Ratings
Hold
1 Buy
5 Hold
0 Sell
Based on 6 analysts giving stock ratings to
Dr.
Martens Plc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DOCS Stock 12 Month Forecast

Average Price Target

86.50p
▲(6.46%Upside)
Based on 6 Wall Street analysts offering 12 month price targets for Dr. Martens Plc in the last 3 months. The average price target is 86.50p with a high forecast of 114.00p and a low forecast of 70.00p. The average price target represents a 6.46% change from the last price of 81.25p.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"53":"53p","84":"84p","115":"115p","68.5":"68.5p","99.5":"99.5p"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":114,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">114.00p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":86.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">86.50p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":70,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">70.00p</span>\n  </div></div>","useHTML":true}}],"tickPositions":[53,68.5,84,99.5,115],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,76.95,79.8,82.65,85.5,88.35,91.2,94.05,96.9,99.75,102.6,105.45,108.3,111.15,{"y":114,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,76.95,77.68461538461538,78.41923076923077,79.15384615384616,79.88846153846154,80.62307692307692,81.3576923076923,82.0923076923077,82.82692307692308,83.56153846153846,84.29615384615384,85.03076923076924,85.76538461538462,{"y":86.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,76.95,76.41538461538462,75.88076923076923,75.34615384615385,74.81153846153846,74.27692307692308,73.74230769230769,73.20769230769231,72.67307692307692,72.13846153846154,71.60384615384615,71.06923076923077,70.53461538461539,{"y":70,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":94.16,"date":1709251200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":87.64,"date":1711929600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":74.79,"date":1714521600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":85.06,"date":1717200000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":69.11,"date":1725148800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":54.85,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":55.1,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":66.15,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":71.23,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":71.47,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.95,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":58.9,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.95,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target114.00pAverage Price Target86.50pLowest Price Target70.00p
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on GB:DOCS
TipRanks AITipRanks
Not Ranked
TipRanks
87p
Hold
7.08%
Upside
Reiterated
07/15/25
Dr. Martens Plc's stock score is influenced by strong technical indicators and positive corporate events. However, high valuation and mixed financial performance, along with challenges highlighted in the earnings call, temper the overall score. The company needs to address profitability and revenue declines to improve its market position.
Deutsche Bank  Analyst forecast on GB:DOCS
Alison LygoDeutsche Bank
Deutsche Bank
80p
Hold
-1.54%
Downside
Reiterated
07/11/25
Deutsche Bank Keeps Their Hold Rating on Dr. Martens Plc (DOCS)
Goldman Sachs Analyst forecast on GB:DOCS
Louise SinglehurstGoldman Sachs
Goldman Sachs
66p75p
Hold
-7.69%
Downside
Reiterated
06/23/25
Dr. Martens Plc (DOCS) Receives a Hold from Goldman Sachs
Barclays
90p
Hold
10.77%
Upside
Reiterated
06/09/25
Barclays Sticks to Its Hold Rating for Dr. Martens Plc (DOCS)
Berenberg Bank Analyst forecast on GB:DOCS
Anne CritchlowBerenberg Bank
Berenberg Bank
114p
Buy
40.31%
Upside
Reiterated
06/06/25
Berenberg Bank Sticks to Their Buy Rating for Dr. Martens Plc (DOCS)
RBC Capital Analyst forecast on GB:DOCS
Piral DadhaniaRBC Capital
RBC Capital
60p90p
Hold
10.77%
Upside
Reiterated
06/06/25
RBC Capital Sticks to Its Hold Rating for Dr. Martens Plc (DOCS)
Morgan Stanley Analyst forecast on GB:DOCS
Edouard AubinMorgan Stanley
Morgan Stanley
70p
Hold
-13.85%
Downside
Reiterated
06/05/25
Hold Rating on Dr. Martens Plc Amid Mixed Financial Performance and Strategic Shifts
HSBC
60p85p
Hold
4.62%
Upside
Reiterated
12/17/24
Dr. Martens Plc (DOCS:LN) PT Raised to GBP0.85 at HSBCHSBC analyst Charlie Rothbarth raised the price target on Dr. Martens Plc (DOCS:LN) to GBP0.85 (from GBP0.60) while maintaining a Hold rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on GB:DOCS
TipRanks AITipRanks
Not Ranked
TipRanks
87p
Hold
7.08%
Upside
Reiterated
07/15/25
Dr. Martens Plc's stock score is influenced by strong technical indicators and positive corporate events. However, high valuation and mixed financial performance, along with challenges highlighted in the earnings call, temper the overall score. The company needs to address profitability and revenue declines to improve its market position.
Deutsche Bank  Analyst forecast on GB:DOCS
Alison LygoDeutsche Bank
Deutsche Bank
80p
Hold
-1.54%
Downside
Reiterated
07/11/25
Deutsche Bank Keeps Their Hold Rating on Dr. Martens Plc (DOCS)
Goldman Sachs Analyst forecast on GB:DOCS
Louise SinglehurstGoldman Sachs
Goldman Sachs
66p75p
Hold
-7.69%
Downside
Reiterated
06/23/25
Dr. Martens Plc (DOCS) Receives a Hold from Goldman Sachs
Barclays
90p
Hold
10.77%
Upside
Reiterated
06/09/25
Barclays Sticks to Its Hold Rating for Dr. Martens Plc (DOCS)
Berenberg Bank Analyst forecast on GB:DOCS
Anne CritchlowBerenberg Bank
Berenberg Bank
114p
Buy
40.31%
Upside
Reiterated
06/06/25
Berenberg Bank Sticks to Their Buy Rating for Dr. Martens Plc (DOCS)
RBC Capital Analyst forecast on GB:DOCS
Piral DadhaniaRBC Capital
RBC Capital
60p90p
Hold
10.77%
Upside
Reiterated
06/06/25
RBC Capital Sticks to Its Hold Rating for Dr. Martens Plc (DOCS)
Morgan Stanley Analyst forecast on GB:DOCS
Edouard AubinMorgan Stanley
Morgan Stanley
70p
Hold
-13.85%
Downside
Reiterated
06/05/25
Hold Rating on Dr. Martens Plc Amid Mixed Financial Performance and Strategic Shifts
HSBC
60p85p
Hold
4.62%
Upside
Reiterated
12/17/24
Dr. Martens Plc (DOCS:LN) PT Raised to GBP0.85 at HSBCHSBC analyst Charlie Rothbarth raised the price target on Dr. Martens Plc (DOCS:LN) to GBP0.85 (from GBP0.60) while maintaining a Hold rating.
Stocks with the Highest Top Analyst Consensus in the Consumer Cyclical Sector
Find stocks in the Consumer Cyclical sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Dr. Martens Plc

1 Month
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-6.10%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 0.00% of your transactions generating a profit, with an average return of -6.10% per trade.
3 Months
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-3.20%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -3.20% per trade.
1 Year
Anne CritchlowBerenberg Bank
Success Rate
0/1 ratings generated profit
0%
Average Return
-3.20%
reiterated a buy rating 2 months ago
Copying Anne Critchlow's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -3.20% per trade.
2 Years
xxx
Success Rate
0/1 ratings generated profit
0%
Average Return
-3.20%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -3.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DOCS Analyst Recommendation Trends

Rating
Jan 25
Feb 25
May 25
Jun 25
Jul 25
Strong Buy
0
1
1
1
0
Buy
0
0
0
1
1
Hold
10
6
6
9
14
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
10
7
7
11
15
In the current month, DOCS has received 1 Buy Ratings, 14 Hold Ratings, and 0 Sell Ratings. DOCS average Analyst price target in the past 3 months is 86.50.
Each month's total comprises the sum of three months' worth of ratings.

DOCS Financial Forecast

DOCS Earnings Forecast

Next quarter’s earnings estimate for DOCS is -0.01p with a range of -0.01p to -0.01p. The previous quarter’s EPS was 0.04p. DOCS beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 59.73% of the time in the same period. In the last calendar year DOCS has Outperformed its overall industry.
Next quarter’s earnings estimate for DOCS is -0.01p with a range of -0.01p to -0.01p. The previous quarter’s EPS was 0.04p. DOCS beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 59.73% of the time in the same period. In the last calendar year DOCS has Outperformed its overall industry.

DOCS Sales Forecast

Next quarter’s sales forecast for DOCS is 331.77M with a range of 331.77M to 331.77M. The previous quarter’s sales results were 463.00M. DOCS beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 55.59% of the time in the same period. In the last calendar year DOCS has Outperformed its overall industry.
Next quarter’s sales forecast for DOCS is 331.77M with a range of 331.77M to 331.77M. The previous quarter’s sales results were 463.00M. DOCS beat its sales estimates 50.00% of the time in past 12 months, while its overall industry beat sales estimates 55.59% of the time in the same period. In the last calendar year DOCS has Outperformed its overall industry.

DOCS Stock Forecast FAQ

What is GB:DOCS’s average 12-month price target, according to analysts?
Based on analyst ratings, Dr. Martens Plc’s 12-month average price target is 86.50.
    What is GB:DOCS’s upside potential, based on the analysts’ average price target?
    Dr. Martens Plc has 6.46% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Dr. Martens Plc a Buy, Sell or Hold?
          Dr. Martens Plc has a consensus rating of Hold, which is based on 1 buy ratings, 5 hold ratings and 0 sell ratings.
            What is Dr. Martens Plc’s share price target?
            The average share price target for Dr. Martens Plc is 86.50. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is 114.00p ,and the lowest forecast is 70.00p. The average share price target represents 6.46% Increase from the current price of 81.25p.
              What do analysts say about Dr. Martens Plc?
              Dr. Martens Plc’s analyst rating consensus is a Hold. This is based on the ratings of 6 Wall Streets Analysts.
                How can I buy shares of Dr. Martens Plc?
                To buy shares of GB:DOCS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis